作者: Ulrich Kronthaler , Wilfried Wormsbächer , Uwe Liebing , Thomas Weimer , Stefan Schulte
DOI:
关键词:
摘要: The present invention relates to the fields of Factor VII (FVII) and VIIa (FVIIa) albumin linked polypeptides. More specifically, cDNA sequences coding for human derivatives genetically fused a serum which may be by oligonucleotides code intervening peptidic linkers such encoded exhibiting improved stability extended functional plasma half-life, recombinant expression vectors containing sequences, host cells transformed with vectors, polypeptides do have biological activities unmodified wild type protein but having prolonged shelf-life processes manufacture proteins their derivatives. also covers transfer vector use in gene therapy, comprises modified DNA sequences.